drugset / Trial / NCT07840365
Optimal Anti-Thrombotic Management Following Percutaneous Left Atrial Appendage Occlusion
RandomizedParallel-groupOpen-labelPrevention
Summary
This randomized study was designed to compare two antithrombotic regimens (long-term half-dose apixaban vs long-term aspirin after 45-days of full-dose apixaban) after successful Watchman implantation.
Timeline
- Start
- 2026-09-01
- Primary completion
- 2028-12-15
- Completion
- 2029-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Apixaban | Small molecule | 2.5 mg | — |
| Comparator | Apixaban | Small molecule | 5 mg | — |
| Comparator | Aspirin | Small molecule | — | — |